Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003819 |
---|---|
Receipt number | R000004604 |
Scientific Title | A phase ll study of combination therapy with Panitumumab plus CPT-11 for advanced and/or recurrent colon-rectal cancer with wild type KRAS which has prior therapy of fluoropylimidine, oxaliplatin or CPT-11 (OGSG 1001) |
Date of disclosure of the study information | 2010/07/15 |
Last modified on | 2020/01/05 13:38:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/24 18:48:41 | ||
2 | Update | 2010/08/04 18:01:12 | Name of person sending information Name of person sending information Address |
|
3 | Update | 2010/10/25 16:05:22 | Recruitment status |
|
4 | Update | 2010/10/25 16:06:28 | Acronym Acronym |
|
5 | Update | 2010/10/25 16:09:42 | Organization Organization Division name Division name Address TEL Name of person sending information |
|
6 | Update | 2011/03/04 17:26:06 | Last follow-up date |
|
7 | Update | 2011/11/22 19:06:44 | Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2012/06/24 23:08:21 | Public title Public title Acronym Acronym |
|
9 | Update | 2012/06/24 23:12:14 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 |
|
10 | Update | 2012/07/24 20:51:14 | Recruitment status Last follow-up date |
|
11 | Update | 2013/06/24 22:37:27 | Anticipated trial start date |
|
12 | Update | 2014/06/25 14:33:50 | Recruitment status |
|
13 | Update | 2014/07/27 22:42:18 | Date analysis concluded |
|
14 | Update | 2015/06/11 23:31:27 | Last name of lead principal investigator Last name of lead principal investigator |
|
15 | Update | 2015/06/19 21:05:59 | Results Results |
|
16 | Update | 2018/04/30 23:06:40 | Email Name of primary person or sponsor Organization |
|
17 | Update | 2018/04/30 23:15:10 | Organization |
|
18 | Update | 2018/04/30 23:17:46 | Organization |
|
19 | Update | 2018/05/10 20:21:56 | Email |
|
20 | Update | 2020/01/05 13:38:53 | Date of IRB |